Michael Burgess, MD @michaelcburgess
BREAKING: The FDA has approved the first gene therapy to treat adults with Hemophilia B. This is a huge milestone in Hemophilia treatment. I am thankful for this new, safe, and effective treatment option. — PolitiTweet.org
U.S. FDA @US_FDA
Today, we approved a gene therapy for the treatment of adults with Hemophilia B who currently use Factor IX prophyl… https://t.co/Fh0ck49rF0